7 patents currently held
9 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Dec 2028. from the record
Of the 9 now held by other companies, 7 name Novilux LLC as their current owner, and 2 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
7
Ending by 2030
Dec 2028
Next term end
2
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Oct 2029 · Medium confidence
Also notable
Ends Nov 2029 · High confidence
Method of analysis for determining a specific protein in blood samples using fluorescence spectrometry
US 9,040,305
Cited by 48 later US patents, top 10% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Scanning Analyzer for Single Molecule Detection and Methods of Use
US 7,914,734
The most cited patent in this portfolio, cited by 100 later US patents, top 10% of utility patents granted in 2011 in our data. Protection runs to 2029.
Formerly held, still cited
Notable
Ends Nov 2027 · High confidence
Cited by 66 later US patents, top 25% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
now held by Novilux, LLC
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jul 19, 2027The maintenance fee for Scanning Analyzer for Single Molecule Detection and Methods of Use (US 9,239,284) comes due Jul 19, 2027. Unpaid by Jan 19, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Scanning Analyzer for Single Molecule Detection and Methods of Use | 6 in force | to Nov 2029 |
| Method of analysis for determining a specific protein in blood samples using fluorescence spectrometry | 1 in force | to Oct 2029 |
Patents held now
Soonest term end first.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,264,684 | Scanning Analyzer for Single Molecule Detection and Methods of Use In force · High confidence | In force | High confidence | |
| US 8,634,075 | Scanning Analyzer for Single Molecule Detection and Methods of Use In force · High confidence | In force | High confidence | |
| US 8,917,392 | Scanning Analyzer for Single Molecule Detection and Methods of Use In force · Medium confidence | In force | Medium confidence | |
| US 9,239,284 | Scanning Analyzer for Single Molecule Detection and Methods of Use In force · Medium confidence | In force | Medium confidence | |
| US 10,107,752 | Scanning Analyzer for Single Molecule Detection and Methods of Use In force · Medium confidence | In force | Medium confidence | |
| US 9,040,305 | Method of analysis for determining a specific protein in blood samples using fluorescence spectrometry In force · Medium confidence | In force | Medium confidence | |
| US 7,914,734 | Scanning Analyzer for Single Molecule Detection and Methods of Use In force · High confidence | In force | High confidence |
Also on record, not counted in the 7: 9 patents in force now held by others · 7 patents ended · 27 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 terminal disclaimer is on file with no resolved reference. No cap is applied and none is guessed